(Q46128004)
Statements
1 reference
Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III. (English)
1 reference
Jane D Robertson
1 reference
Nick A Botwood
1 reference
Mace L Rothenberg
1 reference
Hans-Joachim Schmoll
1 reference
1 January 2009
1 reference
1 reference
8
1 reference
1
1 reference
59-60
1 reference
Identifiers
1 reference
1 reference